explore -WSS

explore

author：fashion 2025-09-30 18:20:23 - browse：6

Two people stare at a keyhole in a human head in between them, as the short-haired person on the left holds a key — first opinion coverage from STAT — Adobe

In many ways, psychiatry is still flying blind. People experiencing mental health conditions are prescribed various drugs until one (or a combination) finally works — a painful process that can take years. As a psychiatrist and neuroscientist, I became increasingly impatient and frustrated with this ineffective way of treating patients. This guided the core question behind my research: Can biology explain how people with the same psychiatric disorder respond differently to the same treatment?

Since I first began exploring this question more than a decade ago, mental illness has become a global epidemic. Despite significant efforts, progress in psychiatric drug development has remained disappointingly slow. There have been a few notable approvals in recent years, and a renewal of interest by Big Pharma, following a retreat from psychiatric research in the mid to late 2000s. But the landscape remains predominantly marked by failures and a dry drug development pipeline. Approved drugs follow the same pattern of prescribing via guesswork, with most patients not responding to a given drug. This cycle of trial-and-error drug development producing trial-and-error treatment arises from a simple source: We have not systematized a process for learning from our failures and successes.

Related: A ‘renaissance in neuroscience’ could deliver a fresh crop of psychiatric medicines

For example, take depression: While the rise of selective serotonin reuptake inhibitors (SSRIs) in the 1980s and 1990s seemed to provide a solution, seminal studies in the 2000s exposed fundamental limitations of our treatment options. Antidepressants are widely prescribed, but their efficacy relative to placebo is modest.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： Mom launches Girl Scout troop for LGBTQ youth in Texas

entertainment

WSS

Former reverend arrested for allegedly killing 8

Biden administration plans revamp of organ transplant system

Living organ donors deserve priority status for transplants

Roche’s Alnylam deal shows drug firms interested in heart drugs

Device maker Teleflex to acquire urology company for $600M

Science's Marcia McNutt, trailblazer for women, encounters sexism scandal

entertainment

explore

Related: A ‘renaissance in neuroscience’ could deliver a fresh crop of psychiatric medicines

leisure time

Medicare details structure of new drug price negotiation program

Democrats decry new health bill for going easy on private equity

In Memoriam: Notable people who died in 2023

Sea level rise could wash away turtle breeding grounds around the world, researchers say

Anesthesiologist group: stop taking Ozempic before surgery

CDC Director Mandy Cohen on transparency, trust, and health

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

A public health expert passes on football's full body collisions for youths

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Biden administration plans revamp of organ transplant system

explore

Device maker Teleflex to acquire urology company for $600M

Patients, doctors are clashing about side effects of hormonal birth control

'Investigate these claims': UFO transparency at center of House hearing

STAT Report: Patient voices and perspectives

Tennessee law changes starting July 1 will restrict trans health care and fund more school safety

CDC Director Mandy Cohen on transparency, trust, and health

explore

entertainment

knowledge

focus